Company intelligence / Profile preview

NVP Healthcare Co., Ltd.

Gyeonggi-do, South Koreanvp-healthcare.com ↗

Ownership: Private
Development stage: Phase 3

Overview

NVP Healthcare has completed Phase 1 clinical trials for NVP-2203 (evaluating safety and pharmacokinetics) and NVP-1805 (comparing pharmacokinetics of the drug with coadministration of its components). NVP-2203 has advanced to Phase 3 for cardiovascular diseases.

Therapeutic areas: Cardiovascular
Modalities: Small molecule drugsBiological products
Industry: Biotech

Drug pipeline

16 assets

NVP-2203-R2

15 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on NVP Healthcare Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NVP Healthcare Co., Ltd..

Explore the full profile